Peter E. Boyd, SVP-Bus. Process & Info. Technology at Aquestive Therapeutics, Inc. (AQST), bought 600 shares at $3.81 ($2K) on 2019-08-12, disclosed to the SEC on 2019-08-13.
Open-market purchase of $2k AQST by SVP-Bus. Process & Info. Technology. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| AQST | SELL | 2025-09-29 | $63K | — | Filing → |
| AQST | SELL | 2025-09-08 | $80K | — | Filing → |
| AQST | BUY | 2022-06-15 | $4K | — | Filing → |